| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |